Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 25;15(12):1935–1942. doi: 10.1016/j.jtho.2020.08.018

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Representative images of HRCT. (A) Probable UIP pattern; baseline HRCT revealed a subpleural reticular shadow predominant in lower lobes without a honeycomb lung. This patient continued atezolizumab without developing pneumonitis. (B) UIP pattern; baseline HRCT revealed a subpleural basal predominant reticular shadow and a honeycomb lung. (C) This patient developed grade 3 pneumonitis on day 20 of atezolizumab initiation. HRCT, high-resolution computed tomography; UIP, usual interstitial pneumonia.